{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:51:16Z","timestamp":1772711476701,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd012188","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000}}],"reference-count":85,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012188.pub2","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T16:48:19Z","timestamp":1483462099000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Gabapentin for fibromyalgia pain in adults"],"prefix":"10.1002","volume":"2018","author":[{"given":"Tess E","family":"Cooper","sequence":"first","affiliation":[{"name":"Pain Research Unit, Churchill Hospital; Cochrane Pain, Palliative and Supportive Care Group; Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD012188.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/art.22457","article-title":"Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"56","author":"Arnold","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0002|cit2","unstructured":"Mouzopoulos G Tsembeli A Skevofilax I Nomikos G Vasiliadis V Duloxetine is superior to gabapentin in the treatment of the fibromyalgia Pain Practice Blackwell Publishing Inc 2014 45"},{"issue":"4","key":"10.1002\/14651858.CD012188.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.37842","article-title":"The fibromyalgia family study: a genome-wide linkage scan study","volume":"65","author":"Arnold","year":"2013","journal-title":"Arthritis and Rheumatism"},{"issue":"7","key":"10.1002\/14651858.CD012188.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1526-4637.2011.01139.x","article-title":"Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin","volume":"12","author":"Backonja","year":"2011","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"12","key":"10.1002\/14651858.CD012188.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.pain.2014.09.003","article-title":"The effect of a combination of gabapentin and donepezil in an experimental pain model in health volunteers: Results of a randomised controlled trial","volume":"155","author":"Boyle","year":"2014","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","article-title":"Pathophysiology of fibromyalgia","volume":"122","author":"Bradley","year":"2009","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"631756","DOI":"10.1155\/2014\/631756","article-title":"Gabapentin in acute postoperative pain management","volume":"2014","author":"Chang","year":"2014","journal-title":"Biomed Research International"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jpain.2010.01.267","article-title":"The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study","volume":"11","author":"Choi","year":"2010","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD012188.pub2-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008244.pub3","article-title":"Milnacipran for pain in fibromyalgia in adults","author":"Cording","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00482-012-1167-z","article-title":"Fibromyalgia syndrome. General principles and coordination of clinical care and patient education","volume":"26","author":"Eich","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0014|cit14","unstructured":"Electronic Medicines Compendium http:\/\/emc.medicines.org.uk\/"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0015|cit15","unstructured":"Effective Practice Organisation of Care (EPOC) 23. Worksheets for preparing a Summary of Findings using GRADE. Resources for review authors Oslo: Norwegian Knowledge Centre for the Health Services Available at: http:\/\/epoc.cochrane.org\/epoc-specific-resources-review-authors (accessed 30 November 2016) 2015"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Research Management"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0018|cit18","first-page":"2458","article-title":"Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study","volume":"26","author":"Forseth","year":"1999","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0021|cit21","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011. www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD012188.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","article-title":"Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials","volume":"145","author":"H\u00e4user","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/acr.20328","article-title":"Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"63","author":"H\u00e4user","year":"2011","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.pain.2013.03.034","article-title":"Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome","volume":"154","author":"H\u00e4user","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD012188.pub2-BIB0026|cit26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/j.1532-2149.2014.00453.x","article-title":"Fibronyalgia syndrome - a somatoform disorder?","volume":"18","author":"H\u00e4user","year":"2014","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"1","author":"H\u00e4user","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.1002\/14651858.CD012188.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2377-11-55","article-title":"Fibromyalgia and neuropathic pain--differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia","volume":"11","author":"Koroschetz","year":"2011","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1056\/NEJMp0808659","article-title":"The Neurontin legacy - marketing through misinformation and manipulation","volume":"360","author":"Landefeld","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00482-010-0937-8","article-title":"Influence of depression on fibromyalgia: A systematic review","volume":"24","author":"Lange","year":"2010","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00296-010-1678-9","article-title":"Candidate gene studies of fibromyalgia: a systematic review and meta-analysis","volume":"32","author":"Lee","year":"2012","journal-title":"Rheumatology International"},{"issue":"1","key":"10.1002\/14651858.CD012188.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"Epub ahead of p","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"July","author":"Macfarlane","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012188.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/j.pain.0000000000000314","article-title":"A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population","volume":"157","author":"Mansfield","year":"2016","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0039|cit39","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"3","key":"10.1002\/14651858.CD012188.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0041|cit41","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD012188.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD012188.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012188.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012188.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses--do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012188.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD012188.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD012188.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD012188.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012188.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD012188.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions--individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"8","key":"10.1002\/14651858.CD012188.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000088","article-title":"Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting","volume":"156","author":"Moore","year":"2015","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/acr.20118","article-title":"Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Tr\u00f8ndelag Health Study","volume":"62","author":"Mork","year":"2010","journal-title":"Arthritis Care & Research"},{"issue":"1","key":"10.1002\/14651858.CD012188.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0060|cit60","unstructured":"Cochrane Pain Palliative and Supportive Care Group PaPaS author and referee guidance http:\/\/papas.cochrane.org\/papas-documents"},{"issue":"8","key":"10.1002\/14651858.CD012188.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Current Pain and Headache Reports"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0062|cit62","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD012188.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/AJP.0b013e318258993e","article-title":"Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN)","volume":"29","author":"Sang","year":"2013","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00482-012-1174-0","article-title":"Etiology and pathophysiology of fibromyalgia syndrome","volume":"26","author":"Sommer","year":"2012","journal-title":"Schmerz"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia--responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2474-12-125","article-title":"Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response","volume":"12","author":"Straube","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"6","key":"10.1002\/14651858.CD012188.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2710.2009.01144.x","article-title":"Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis","volume":"35","author":"Tzellos","year":"2010","journal-title":"Journal of Clinical Pharmacology and Therapeutics"},{"issue":"20","key":"10.1002\/14651858.CD012188.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMsa0906126","article-title":"Outcome reporting in industry-sponsored trials of gabapentin for off-label use","volume":"361","author":"Vedula","year":"2009","journal-title":"The New England Journal of Medicine"},{"issue":"9859","key":"10.1002\/14651858.CD012188.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD012188.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"e0138024","DOI":"10.1371\/journal.pone.0138024","article-title":"The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey","volume":"10","author":"Walitt","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/14651858.CD012188.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001133.pub2","article-title":"Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012188.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005452","article-title":"Gabapentin for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012188.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012188.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD012188.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD012188.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"65","author":"Wolfe","year":"2013","journal-title":"Arthritis Care and Research"},{"issue":"7","key":"10.1002\/14651858.CD012188.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012188.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1002\/14651858.CD012188.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010782","article-title":"Anticonvulsants for fibromyalgia","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012188.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012188.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012188.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T10:47:41Z","timestamp":1675766861000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012188.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":85,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012188.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]}}}